Exergames on Shoulder Pain and Motor Function
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03716206 |
|
Recruitment Status : Unknown
Verified March 2019 by Yea-Ru Yang, National Yang Ming University.
Recruitment status was: Recruiting
First Posted : October 23, 2018
Last Update Posted : March 29, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Shoulder Pain Stroke | Device: Exergame Other: Physical therapy | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 60 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Single (Outcomes Assessor) |
| Primary Purpose: | Treatment |
| Official Title: | Effects of Exergames on Post-stroke Shoulder Pain and Motor Function |
| Actual Study Start Date : | November 21, 2018 |
| Estimated Primary Completion Date : | August 1, 2019 |
| Estimated Study Completion Date : | December 31, 2019 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: exergames group
The exergames intervention is one hour per day, four or five days per week for three weeks.
|
Device: Exergame
This intervention included upper limb task-orientation training, upper limb coordination training, shoulder range of motion and upper limb activity training. |
|
Active Comparator: conventional group
The conventional group intervention is one hour per day, four or five days per week for three weeks.
|
Other: Physical therapy
This intervention included upper limb task-orientation training, upper limb coordination training, shoulder range of motion and upper limb activity training. |
- Brief Pain Inventory - Short Form [ Time Frame: Change from Baseline at 7 weeks ]To assess the severity of pain and the impact of pain on daily functions. The Brief Pain Inventory - Short Form assess severity of pain, impact of pain on daily function, location of pain, pain medications and amount of pain relief in the past 24 hours or the past week. It is available in a short (nine items) form.
- Visual analogue scale [ Time Frame: Change from Baseline at 7 weeks ]The VAS provides a continuous scale for magnitude estimation and consists of a straight line, the ends of which are defined in terms of the extreme limits of pain experience. VAS is a straight horizontal line of fixed length, usually 100 mm. The ends are defined as the extreme limits of the parameter to be measured (pain) orientated from the left (worst) to the right (best).
- Wolf motor function test [ Time Frame: Change from Baseline at 7 weeks ]This test was designed to assess the motor ability of patients with moderate to severe upper extremity motor deficits in the laboratory and clinic. The WMFT tests a broad range of upper extremity function through two strength measurements and a series of 15 functional tasks that progress from simple movements in proximal joint areas to complex movements in distal joint areas. The final time score will be the median time required for all timed tasks executed. One hundred twenty seconds is the maximum time allowed for each task attempted.
- Fugl-Meyer Assessment [ Time Frame: Change from Baseline at 7 weeks ]The Fugl-Meyer Assessment (FMA) is a stroke-specific, performance-based impairment index. It is designed to assess motor functioning, balance, sensation and joint functioning in patients with post-stroke hemiplegia. The Fugl-Meyer Assessment scale is an ordinal scale that has 3 points for each item. A zero score is given for the item if the subject cannot do the task. A score of 1 is given when the task is performed partially and a score of 2 is given when the task is performed fully. However, reflex activity is measured using 2 points only, with a score of 0 or 2 for absence and presence of reflex respectively. it is common practice to assess all domains separately. The Maximum score in upper limb is 66.
- Shoulder Pain Disability Index [ Time Frame: Change from Baseline at 7 weeks ]The Shoulder Pain and Disability Index (SPADI) is a self-administered questionnaire that consists of two dimensions, one for pain and the other for functional activities. The pain dimension consists of five questions regarding the severity of an individual's pain. Functional activities are assessed with eight questions designed to measure the degree of difficulty an individual has with various activities of daily living that require upper-extremity use.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 20 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Unilateral hemiplegia caused by stroke
- Modified Ashworth Scale ≤2。
- Mini-Mental State Examination ≥24。
- Age ≥20。
- Shoulder pain 。
Exclusion Criteria:
- Shoulder joint contructure
- Forzen shoulder
- Dizzness, lesion of auditory and vision.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03716206
| Contact: Yang Yea-Ru, PhD | +88628267279 | yryang@ym.edu.tw |
| Taiwan | |
| Taipei Veterans General Hospital | Recruiting |
| Taipei, Beitou, Taiwan, 112 | |
| Contact: Yea-Ru Yang +886 228267279 yryang@ym.edu.tw | |
| Responsible Party: | Yea-Ru Yang, Professor, National Yang Ming University |
| ClinicalTrials.gov Identifier: | NCT03716206 |
| Other Study ID Numbers: |
201810003B |
| First Posted: | October 23, 2018 Key Record Dates |
| Last Update Posted: | March 29, 2019 |
| Last Verified: | March 2019 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Shoulder Pain Stroke Motor function |
|
Shoulder Pain Stroke Cerebrovascular Disorders Brain Diseases Central Nervous System Diseases Nervous System Diseases Vascular Diseases |
Cardiovascular Diseases Arthralgia Joint Diseases Musculoskeletal Diseases Pain Neurologic Manifestations |

